Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 1 58-1, 2005, Pages

  Korrapati, Midhun C ^a   Lock, Edward A ^b   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cyclin D1; Extracellular signal regulated kinases 1 2; Phospho retinoblastoma; Tissue repair

Indexed keywords

ACTIVATING PROTEIN 1; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN G1; CYCLINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN; S (1,2 DICHLOROVINYL)CYSTEINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CONTROLLED STUDY; DEATH; DNA BINDING; DNA SYNTHESIS; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; GENE TRANSLOCATION; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION;

EID: 20844440373     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00418.2004     Document Type: Article

References (69)

1. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, and Pestell RG. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270: 23589-23597, 1995.
2. Andreucci M, Michael A, Kramers C, Park KM, Pioquinto R, Chen A, Macheaux T, Haq S, Force T, Alessandrini A, and Bonventre JV. Differential activation in ERK 1/2 phosphatidylionositol-3 kinase Akt/ PKB pathways in renal ischemia. Nephrol Dial Transplant 17: 37, 2002.
3. Apte UM, Limaye PB, Ramaiah SK, Vaidya VS, Bucci TJ, Warbritton A, and Mehendale HM. Upregulated promitogenic signaling via cytokines and growth factors: potential mechanisms of robust liver tissue repair in calorie-restricted rats upon toxic challenge. Toxicol Sci 69: 448-459, 2002.
4. Barros E, Santos O, and Matsumoto K. Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelilal tissue development. Proc Natl Acad Sci USA 92: 4412-4416, 1995.
5. Barton CC, Bucci TJ, Lomax LG, Warbritton AG, and Mehendale HM. Stimulated pulmonary cell hyperplasia underlies resistance to α-naphthylthiourea. Toxicology 143: 167-181, 2000.
6. Blazka ME, Germolec DR, Simeonova P, Bruccoleri A, Pennypacker KR, and Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J Inflamm 47: 138-150, 1995/1996.
7. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14: S55-S61, 2003.
8. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002.
9. Borkan SC and Gullans SR. Molecular chaperones in the kidney. Annu Rev Physiol 64: 503-527, 2002.
10. Cantley L, Barros E, and Gandhi M. Regulation of mitogenesis, motogenesis and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol Renal Fluid Electrolyte Physiol 267: F271-F280, 1994.
11. Centers For Disease Control and Prevention. Chronic kidney failure cases double. http://www.diabetes.org/diabetesnewsarticle.jsp?storyId=6810119 &filename=20041007/ap2004100780842899KidneyFailureEDIT.xml.
12. Chanda S, Mangipudy RS, Warbritton A, Bucci T, and Mehendale HM. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology 21: 477-486, 1995.
13. Chang L and Karin M. Mammalian MAP kinase signaling cascades. Nature 410: 37-40, 2001.
14. Chkhotua AB, Gabusi E, Altimari A, D'Errico A, Yakubovich M, Vienken J, Stefoni S, Chieco P, Yussim A, and Grigioni WF. Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am J Kidney Dis 41: 1303-1313, 2003.
15. Coimbra T, Cieslinski DA, and Humes HD. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol Renal Fluid Electrolyte Physiol 259: F438-F443, 1990.
16. Dhawan P and Richmond A. A novel NF-κB-inducing kinase-MAPK signaling pathway upregulates NF-κB activity in melanoma cells. J Biol Chem 277: 7920-7928, 2002.
17. Digavalli SV and Mehendale HM. 2-Butoxyethanol autoprotection is due to resiliency of newly formed erythrocytes to hemolysis. Arch Toxicol 69: 526-532, 1995.
18. Essani NA, McGuire GM, Manning AM, and Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor κB and expression of E-selectin messenger RNA in hepatocytes, kupffer cells, and endothelial cells in vivo. J Immunol 156: 2956-2963, 1983.
19. Feliers D, Frank MA, and Riley DJ. Activation of cyclin D1/Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 51: 3290-3299, 2002.
20. Ghielli M, Verstrepen WA, Nouwen EJ, and De Broe ME. Regeneration processes in the kidney after acute injury: role of infiltrating cells. Exp Nephrol 6: 502-507, 1998.
21. Greenwell A, Foley JF, and Maronpot RR. An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 59: 251-256, 1991.
22. Herber B, Truss M, Beato M, and Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9: 2105-2107, 1994.
23. 1-to-S-phase transition. Mol Cell Biol 19: 2690-2698, 1999.
24. Huang CC, Takaharu I, Stevens JL, and Bonventre JV. Protection of renal epithelilal cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK 1/2 activation. J Biol Chem 278: 29317-29326, 2003.
25. Huang Q, Dunn RT II, Jayadev S, Disorbo O, Pack FD, Farr SB, Stoll RE, and Blanchard KT. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63: 196-207, 2001.
26. Hung CC, Ichimura T, Stevens JL, and Bonventre JV. Protection,of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J Biol Chem 278: 29317-29326, 2003.
27. Hunter T and Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
28. Ishizuka S, Yano T, Hagiwara K, Sone M, Nihei H, Ozasa H, and Horikawa S. Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem Biophys Res Commun 254: 88-92, 1999.
29. Isotani S, Fujisawa M, Ishimura T, Arakawa S, and Kamidono S. Okadaic acid, an inhibitor of protein phosphatase, exerts a protective effect on ischemia-reperfusion injury in rat kidneys. Transplant Proc 34: 1345-1348, 2002.
30. Kathleen DL. Molecular mechanisms of recovery from acute renal failure. Crit Care Med 31: S572-S581, 2003.
31. Katrien V, Dirk RV, and Zwi NB. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003.
32. Lundberg AS and Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by atleast two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761, 1998.
33. Mangipudy RS, Chanda S, and Mehendale HM. Hepatocellular regeneration: key to thioacetamide autoprotection. Pharmacol Toxicol 77: 182-188, 1995.
34. Mehendale HM, Thakore KN, and Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol 9: 131-139, 1994.
35. Mene P, Polci R, and Festuccia F. Mechanisms of repair after kidney injury. J Nephrol 16: 186-195, 2003.
36. Montesano R, Matsumoto K, and Nakamura T. Identification of a fibroblast derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908, 1991.
37. Morgan DO. Principles of CDK regulation. Nature 374: 131-134, 1995.
38. Nissenson A. Acute renal failure: definition and pathogenesis. Kidney Int 53: S7-S10, 1998.
39. Nolan C and Anderson R. Hospital-aquired acute renal failure. J Am Soc Nephrol 9: 710-718, 1998.
40. Norman J, Tsau YK, Bacay A, and Fine LG. Epidermal growth factor accelerates functional recovery from ischemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci (Colch) 78: 445-450, 1990.
41. Oken DE, Mende CW, Taraba I, and Flamenbaum W. Resistance to acute renal failure afforded by prior renal failure: examination of the role of renal renin content. Nephron 15: 131-142, 1975.
42. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, and Bonventre JV. Inducible nitric oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 278: 27256-27266, 2003.
43. Park KM, Kramers C, Vayssier-Taussat M, Chen A, and Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 227: 2040-2049, 2002.
44. Park SK, Kang MJ, Kim W, and Koh GY. Renal tubule regeneration after ischemic injury is coupled to the upregulation and activation of cyclins and cyclin dependent kinases. Kidney Int 52: 706-714, 1997.
45. Park SK, Kang SK, Lee DY, Kang MJ, Kim SH, and Koh GY. Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth. Kidney Int 51: 762-769, 1997.
46. Park SK, Kim W, Lee CH, and Koh GY. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury. Nephron 86: 306-314, 2002.
47. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, and Proia AD. Etomoxir-induced PPAR'22-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278: F667-F675, 2000.
48. Pruchnicki MC and Dasta JF. Acute renal failure in hospitalized patients. Part 1. Ann Pharmacother 36: 1261-1267, 2002.
49. Puntoni F and Villa-Moruzzi E. Protein phosphatase-1 activation and association with the retinoblastoma protein in colcemid-induced apoptosis. Biochem Biophys Res Commun 266: 279-283, 1999.
50. Sakurai H, Barros E, and Tsukamoto T. An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors. Proc Natl Acad Sci USA 94: 6279-6284, 1997.
51. Sawant SD, Doucet PG, Slob W, Blaylock LB, and Mehendale HM. Experimental mathematical validation of a novel concept of extended 2-butoxyethanol autoprotection. Internat J Toxicol 18: 307-316, 1999.
52. 1/S transition phase in mesangial cells by E2F1. Kidney Int 56: 1238-1241, 1999.
53. 1 cyclins. Cell 73: 1059-1065, 1993.
54. 1 cyclin dependent kinases. Genes Dev 9: 1149-1163, 1995.
55. Siwanon J, Aileen A, Evan CO, David SM, Rhonda DK, and Hiroaki K. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem 279: 51100-51106, 2004.
56. Star R. Treatment of acute renal failure. Kidney Int 54: 1817-1831, 1998.
57. Szeto C, Gillispie KM, and Mathieson PW. Low dose mercuric chloride induces resistance in brown Norway rats to further mercuric chloride by upregulation of interferon-γ. Scand J Immunol 50: 195-201, 1999.
58. Takemura T, Hino S, Okada M, Murata Y, Yanagida H, Ikeda M, Yoshioka K, and Harris RC. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney Int 61: 1968-1979, 2002.
59. Teoh N, Leclercq I, Pena AD, and Farrell G. Low dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 37: 118-128, 2003.
60. Thadhani R, Pascual A, and Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
61. Treinies I, Paterson HF, Hooper S, Wilson R, and Marshall CJ. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol Cell Biol 19: 321-329, 1999.
62. Ulrich S, Guido F, and Keith B. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10: 405-455, 1994.
63. Vaidya VS, Shankar K, Lock EA, Bucci TJ, and Mehendale HM. Renal injury and repair following S-(1,2-dichlorovinyl)-L-cysteine (DCVC) administration to mice. Toxicol Appl Pharmacol 188: 110-121, 2003.
64. Vaidya VS, Shankar K, Lock EA, Bucci TJ, and Mehendale HM. Role of tissue repair in survival from S-(1,2-dichlorovinyl)-L-cysteine (DCVC)-induced acute renal tubular necrosis in the mouse. Toxicol Sci 74: 215-227, 2003.
65. Vaidya VS, Shankar K, Lock EA, Dixon D, and Mehendale HM. Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2 pathway. Toxicol Pathol 31: 604-618, 2003.
66. Wang Z, Chen JK, Wang SW, Moeckel G, and Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol 14: 3147-3154, 2003.
67. Watanabe G, Albanese C, Lee J, Reutens A, Vario G, Henglein B, and Pestell RG. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and SP-1. Mol Cell Biol 18: 3212-3222, 1998.
68. Xu X and Sonntag WE. Growth hormone-induced nuclear translocation of STAT-3 decreases with age: modulation by caloric restriction. Am J Physiol Endocrinol Metab 271: E903-E909, 1996.
69. 1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746, 1997.